Neuren Pharmaceuticals Limited (ASX:NEU)
Australia flag Australia · Delayed Price · Currency is AUD
11.34
+0.33 (3.00%)
Apr 24, 2025, 4:10 PM AEST

Neuren Pharmaceuticals Market Cap

Neuren Pharmaceuticals has a market cap or net worth of 1.38 billion as of April 23, 2025. Its market cap has decreased by -48.01% in one year.

Market Cap
1.38B
Enterprise Value
1.16B
Revenue
216.83M
Ranking
n/a
PE Ratio
10.14
Stock Price
11.34

Market Cap Chart

Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.38B, an increase of 6,499.13%. That is a compound annual growth rate of 23.01%.

History

DateMarket Cap% Change
Apr 23, 20251.38B-13.02%
Dec 31, 20241.59B-50.04%
Dec 29, 20233.18B217.33%
Dec 30, 20221.00B110.88%
Dec 31, 2021474.89M222.46%
Dec 31, 2020147.27M-40.72%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 115.90B
Pro Medicus 21.64B
Cochlear 17.07B
Sonic Healthcare 12.19B
Telix Pharmaceuticals 8.68B
Ramsay Health Care 7.67B
Ansell 4.26B
Mesoblast 2.10B
Market Cap Rankings